Search Results

DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation.

Press Releases

DNA Script Appoints Marc Montserrat as CEO to Drive Long-Term Commercial Growth for Groundbreaking Enzymatic DNA Synthesis Platform

October 18, 2024

·

3 min read

Biotech Bay

DNA Script to Unveil Industry’s Most Versatile On-site, On-Demand DNA Printer at the World’s Largest Synthetic Biology Conference

DNA Script announced the broad commercial availability of the fully automated SYNTAX™ DNA printing platform, which consists of the benchtop STX-200 system, latest biochemistry advancements, robust reagent kits, and intuitive software enhancements.

May 22, 2023

·

4 min read

Biotech Bay

DNA Script Extends Distributorships to Middle East to Expand Access to Same-day Enzymatic DNA Synthesis

DNA Script, a world leader in Enzymatic DNA Synthesis for DNA on demand, has signed distribution agreements in the Middle East with Gulf Scientific Corporation and Eisenberg Ltd. to expand its worldwide footprint of sales, service and support.

October 12, 2022

·

3 min read

Biotech Bay

DNA Script Wins the Grand Prize Trophy at the 2022 French Future Unicorns Ceremony

DNA Script, a world leader in Enzymatic DNA Synthesis for DNA on demand, won the Grand Prize Trophy at the 2022 Future Unicorns Awards, whose ceremony took place on September 15, 2022, at the Bourrienne Hotel.

September 16, 2022

·

3 min read

DNA Synthesis Market Size Will Expand to USD 513.80 Million by 2030

The global DNA synthesis market size was accounted for USD 281.11 million in 2022 and it is predicted to expand around USD 513.80 million by 2030 with a CAGR of 7.83% from 2022 to 2030.

June 27, 2023

·

9 min read

Biotech Bay

French Defense Innovation Agency Investigates the Use of DNA Script’s SYNTAX System to Synthesize Custom qPCR Probes for On-demand Detection of Biothreats

DNA Script, a world leader in Enzymatic DNA Synthesis for DNA on demand, has announced the first successful qPCR assays using primers and probes synthesized by a customer via enzymatic synthesis using the company’s SYNTAX System DNA printer.

June 28, 2022

·

3 min read

Business

DNA Script Appoints Chris Barbazette as Chief Commercial Officer

DNA Script, a world leader in Enzymatic DNA Synthesis for DNA on demand, has added life sciences veteran Chris Barbazette as Chief Commercial Officer to its leadership team.

May 10, 2022

·

3 min read

Biotech Bay

DNA Script Closes $200 Million Series C Financing with Completion of Second Tranche

DNA Script, a pioneer in Enzymatic DNA Synthesis for on-demand DNA printing, announced the completion of its Series C financing, raising $200 million of new capital.

January 4, 2022

·

2 min read

Biotech Bay

DNA Script to Present at 40th Annual J.P. Morgan Healthcare Conference

Company to Present Monday, January 10, 2022, at 2 p.m. EST.

January 5, 2022

·

1 min read